Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02322177 · ClinicalTrials.gov registry record

Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol

A clinical trial of Pregnancy and Inborn Errors of Metabolism, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
2
Enrollment target
2
Study locations

NCT02322177: Completed study of Pregnancy and Inborn Errors of Metabolism, sponsored by National Human Genome Research Institute (NHGRI).

NCT02322177 is a study of Pregnancy and Inborn Errors of Metabolism that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 2 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02322177, a study of Pregnancy and Inborn Errors of Metabolism, has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
2 participants
Enrollment target
2
Study locations

Study Summary

Background: \- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby. Objectives: \- To collect data from the medical records of women with an inborn error of metabolism. Also, to create a pregnancy registry of inborn errors of metabolism. Eligibility: * Women with an inborn error of metabolism who either: * have been pregnant in the past, * are currently pregnant, or * have recently talked with their doctor about becoming pregnant. Design: * This study will collect data only. No extra tests will be done. * Participants will be in the study for the length of their pregnancy and for 1 year after delivery. * Participants will answer questions about their family s health. * The participant s doctor will send their medical records to researchers. These may include data about: * Last health care visit before pregnancy * Blood, urine, ultrasound, or lab results during pregnancy * Delivery and recovery after delivery * Researchers will ask for the test(s) used to confirm pregnancy. * After the participant has her baby, researchers will ask for data about how the baby is doing. This may include when the baby is sitting, walking, talking, etc. * The data will be placed into a database. The database will not include the participant s name or identifying data.

Conditions Studied

Pregnancy Inborn Errors of Metabolism Acidemias

Study Locations (2)

Maryland

  • National Human Genome Research Institute (NHGRI) - Bethesda
  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2014-12-19
Est. Completion 2018-08-20
National Human Genome Research Institute (NHGRI)

185 total trials

What the finished NCT02322177 record still lists

NCT02322177 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.

NCT02322177 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02322177 about?

NCT02322177 is a clinical study titled "Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol". Background: \- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby. Objectives: \- To collect data from the medical records of women with ...

What is the current status of trial NCT02322177?

This trial is currently completed. The enrollment target is 2 participants. The study started on 2014-12-19. Estimated completion is 2018-08-20.

What conditions does trial NCT02322177 study?

This clinical trial studies the following conditions: Pregnancy, Inborn Errors of Metabolism, Acidemias.

Who is sponsoring clinical trial NCT02322177?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02322177 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02322177's enrollment target sits among peer trials

2 192nd of 191 the lowest of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT02322177, the US trial registry maintained by the National Library of Medicine. NCT02322177 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.